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ABSTRACT Vitamin A supplementation of lactating mothers and of infants at the time of diphtheria-pertussis-
tetanus (DPT) and oral polio vaccine (OPV) immunizations have both been suggested as measures to prevent
deficiency among infants. This multicenter randomized, double-blind, placebo-controlled trial was conducted in
Ghana, India and Peru to determine the effect of maternal vitamin A supplementation on breast milk retinol and of
maternal and infant supplementation on infant vitamin A status. Mothers in the intervention group received 60 mg
vitamin A (as retinol palmitate) at 18–42 d postpartum; their infants were given 7.5 mg three times, i.e., at 6, 10 and
14 wk of age with DPT and OPV immunizations. Mothers and infants in the comparison group received a placebo.
Maternal supplementation resulted in higher breast milk retinol at 2 mo postpartum [difference in means 7.1, 95%
confidence interval (CI), 3.4, 10.8 nmol/g fat] and lower proportion of mothers with breast milk retinol  28 nmol/g
fat (15.2 vs. 26.6%, 95% CI of difference 16.6, 4.1%). At 6 and 9 mo, maternal supplementation did not affect
breast milk retinol or the proportion of mothers with low breast milk retinol. Vitamin A supplementation of the
mothers and their infants reduced the proportion of infants with serum retinol  0.7 mol/L (30.4 vs. 37%, 95%
CI of difference13.7, 0.6%) and that with low vitamin A stores as indicated by the modified relative dose response
(MRDR)  0.06 (44.2 vs. 52.9%, 95% CI of difference 16.6, 0.9%) at 6 mo. Supplementation had no effect at
9 mo. The beneficial effect of supplementation on breast milk retinol and infants’ vitamin A status varied by site.
It was greatest in India followed by Ghana and Peru. At the doses used, maternal supplementation improved breast
milk retinol status at 2 mo (P  0.001) and maternal and infant supplementation modestly increased (P  0.03)
infant vitamin A status at 6 mo of age. Additional strategies to improve vitamin A status of 6- to 9-mo-old infants
must be considered. J. Nutr. 132: 3243–3248, 2002.
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Around 1990, clinical or subclinical vitamin A deficiency
existed in an estimated 118 countries in the world and affected
250 million children  5 y old (1). Three independent
meta-analyses of studies of periodic high dose vitamin A
supplementation to children aged 6 mo to 5 y have reported a
20–30% reduction in all-cause mortality (2–4). Many devel-
oping countries have vitamin A supplementation programs for
children at this age. Vitamin A supplementations to lactating
mothers to improve infant’s vitamin A status through in-
creased breast milk retinol, and to infants at 6, 10 and 14 wk
with vaccines under the Expanded Program for Immunization
(EPI)4 have been suggested as measures to prevent deficiency
in the first 6–9 mo of life (5).
A randomized, double-blind, placebo-controlled multi-
center trial was coordinated by the WHO to determine the
benefits and safety of maternal and immunization-linked vita-
min A supplementation in Ghana, India and Peru. The inter-
vention was 60 mg vitamin A to mothers within 6 wk of
delivery and 7.5 mg to their infants at 6, 10 and 14 wk of age
with diphtheria-pertussis-tetanus (DPT) and oral polio vac-
cine (OPV) immunizations. The findings of this trial that
relate to safety and the effect on morbidity, mortality and
vitamin A status of infants have already been published (6).
The publication reported only overall results related to the
effect on infant vitamin A status. In this paper, we now
present the overall and site-specific data on the effect of
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maternal supplementation on breast milk retinol and site-
specific data on the effect of combined maternal and infant
supplementation on infant vitamin A status.
SUBJECTS AND METHODS
A total of 9424 mother-infant pairs were enrolled in the trial,
18–28 d postpartum in India and Peru and 21–42 d after delivery in
Ghana. They were randomly assigned to receive vitamin A or pla-
cebo. The mothers were administered a single dose of 60 mg vitamin
A or placebo at enrollment.5 Infants of mothers in the vitamin A
group received 7.5 mg vitamin A at each of the EPI immunizations at
6, 10 and 14 wk of age in Ghana and India and at 2, 3 and 4 mo of
age in Peru. Infants of mothers in the placebo group received a
placebo at each immunization. At 9 mo of age, all infants were
administered vitamin A, 7.5 mg to the vitamin A group and 30 mg to
those in the placebo group, with the measles immunization, according
to the national program policies. Vitamin A was provided as retinol
palmitate with minute amounts of vitamin E; the placebo was soy-
bean oil.
At each study site, 25% of the 4000 mother-infant pairs that
were part the main study were randomly selected for the biochemical
substudy; at least 80% of these gave breast milk and blood samples. A
breast milk sample was collected from all of these mothers at enroll-
ment. A second breast milk sample was obtained at 2, 6 or 9 mo
postpartum in randomly selected subgroups. Blood samples were ob-
tained at 6 wk from infants whose mothers were selected to provide
a breast milk sample at 2 mo. Blood samples of infants whose mothers
were selected for a second breast milk sample at 6 and 9 mo were
obtained at the same time. This strategy ensured that each infant in
the biochemical substudy provided only one blood sample and the
mother provided two breast milk samples, one at enrollment and the
second at the time when the blood sample was collected from the
infant.
Informed written consent was obtained from parent(s) before
enrollment. The study was approved by the appropriate ethics review
committees of all participating institutions and the WHO ethics
review board.
Sample size. The sample size was calculated to allow a site-
specific analysis. In the vitamin A and placebo groups in Ghana,
India and Peru,100 infants from each group were selected for breast
milk and infant blood sampling at 6 wk, 6 mo, 9 mo and 1 y. This
sample size was adequate to detect a 0.5 SD difference in mean serum
retinol and mean breast milk retinol and a 40% reduction in the
proportion of infants with modified relative dose response (MRDR)
 0.06 with 95% confidence and 80% power (7).
Laboratory methods. Breast milk samples (10 mL) were collected
in amber-colored glass bottles from either one of the breasts using a
breast pump. Because the infants were breast-fed on demand, breast
milk samples were collected independently of the time since the
previous feed, usually between 0900 and 1200 h. Three capillary tubes
were filled with breast milk; creamatocrit, which was used to estimate
the fat content of breast milk, was measured as described (8). Breast
milk samples were stored at 20°C or below. The temperature of the
freezer was checked twice daily.
Venous blood samples in India and Peru, and capillary blood
samples in Ghana were collected from infants to perform serum
retinol and MRDR assays. An analog of vitamin A, didehydroretinol,
in a dose of 150 g was administered to the infant on the morning of
the day the blood sample was drawn. After 5 h, a blood sample was
drawn into a glass tube covered with aluminum foil. The blood was
allowed to clot for 20 min and serum separated by centrifugation at
10,000  g for 5 min. The sera were stored at 20°C in polypro-
pylene tubes covered with aluminum foil to protect from light.
Biochemical analyses using the same standardized methodology
were conducted independently at each of the three sites (9). Breast
milk samples were homogenized to 200 L of milk, 100 L of internal
standard (didehydroretinol acetate), 160 L of a 30% solution of
potassium hydroxide in alcohol and 500 L of ethanol was added.
The tubes were capped and the mixture saponified for 1 h at 45°C
with periodic mixing. n-Hexane (1 mL) was added, vortexed for 30 s
and centrifuged at 2500  g for 5 min. Vitamin A was extracted into
the hexane layer and the hexane evaporated under nitrogen. The
extracted vitamin A was redissolved in mobile phase (90% methanol,
10% water), and a 25 L sample was injected into the HPLC
(Waters, Milford, MA).
The serum (100–500 L) was first treated with an equal volume
of alcohol. Retinyl acetate in methanol was added as an internal
standard and vitamin A was extracted twice with an equal volume of
hexane. The combined layers were pooled and evaporated under
nitrogen. The sample was resuspended in a known volume of mobile
phase and injected into the HPLC column. Retinol and didehydro-
retinol in serum and breast milk were measured by HPLC on re-
versed-phase C-18 columns with a 90% methanol/10% water mobile
phase. The detection wavelengths were 325 nm for breast milk retinol
and 350 nm for didehydroretinol. Peak areas were measured by an
automatic integrator and didehydroretinol and retinol quantitated
against authentic standards.
Internal quality control was maintained by analysis of three ali-
quots of a reference pool of serum or breast milk samples in each
sample lot. The two pools had assigned values set against standard
reference material procured from National Institute of Standards and
Technology, Gaithersburg, MD. The analysis of a lot was repeated if
the intralot variation exceeded 5%. For external quality control, each
of the three laboratories took part in a standardization program of the
U.S. National Institute of Standards and Technology throughout the
study. Of nine rounds analyzed (three times a year) in each of the
three laboratories (27 analyses), all but one were within 2 SD of
reference values.
Data analysis. Simple comparisons of means by treatment group
were used to determine the effect of supplementation on serum and
breast milk retinol concentrations. Because the breast was not com-
pletely emptied and only a casual sample of breast milk was taken,
breast milk retinol was standardized for the fat in the sample. Crea-
matocrit was related to the fat content measured by extraction on the
basis of measurements made on 25 breast milk samples measured by
both methods (linear regression analysis: r  0.95, P  0.0001).
Using the linear equation obtained, the mean crematocrit of each
breast milk sample was converted to fat concentration (g/L). Breast
milk retinol concentrations are reported relative to milk fat (nmol/g).
According to the criteria established by the WHO, values  28
nmol/g fat indicate low breast milk vitamin A concentration and
values  0.7 mol/L indicate low serum retinol (9). The didehydro-
retinol to retinol the ratio (MRDR) was used as an indicator of
vitamin A stores in the infants. The usual cut-off value of 0.06 for
identifying children with low vitamin A stores was used for infants in
this study (10–12). Because experience with the use of MRDR in
infancy is limited and 50% infants had MRDR  0.06 at 6 mo of
age, we also used 0.09 and 0.12 cut-off values to achieve greater
specificity in identifying infants of low vitamin A status (13).
The analysis was performed using SPSS for Windows (version 8.0,
Chicago, IL) software. Student’s t test for continuous data and 2 test
for qualitative variables were used to test the study hypotheses. The
difference in means and proportions between vitamin A and control
groups and their 95% confidence intervals (CI) were calculated (14).
Values in the text are means  SD or mean differences and 95% CI.
RESULTS
At enrollment, there were no differences in age, sex,
weight, breast-feeding status, maternal age, night blindness
during pregnancy, parental education, family size and birth
order in the infants in the vitamin A and placebo groups,
overall and within each site. The baseline breast milk retinol
concentrations also did not differ between subjects who were
randomly assigned to vitamin A and placebo groups, overall
and within each site (Table 1).
5 Conversion factors: 1 mg vitamin A  1000 g retinol equivalents (RE)
 3333 international units (IU).
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The results are presented overall and by site. Site-specific
results are presented because the mother-infant pairs in the
study were from rural (Ghana), periurban (Peru) and urban
slum (India) populations from three different continents and
differed in several baseline characteristics. The median years of
schooling of mothers were highest in Peru, followed by India
and Ghana. Indian infants were the most malnourished at
enrollment, with a mean weight0.4 kg lower than Ghanaian
and 0.7 kg lower than Peruvian infants. Further, the mean
breast milk retinol among controls at baseline was lowest in
India (38.7  27.4 nmol/g fat), followed by Peru (55.7  23.2
nmol/g fat) and Ghana (58.8  24.2 nmol/g fat). The propor-
tion of infants in the placebo group at 6 wk in the three sites
with serum retinol  0.7 mol/L was also highest in India
(81.1%), followed by Ghana (60.2%) and Peru (45.1%).
Effect of maternal supplementation on breast milk retinol
Overall analysis. At 2 mo postpartum, vitamin A supple-
mentation improved breast milk vitamin A (Table 2). Breast
milk retinol was higher (difference in means, 7.1 nmol/g fat,
95% CI 3.4, 10.8) and the proportion of mothers with breast
milk retinol  28 nmol/g fat was lower (15.2 vs. 26.6%, 95%
CI of difference 16.6, 4.1%) in the vitamin A group.
At 6 and 9 mo postpartum, mean breast milk retinol con-
centrations and the proportion of mothers with low breast
milk retinol did not differ between the two groups (Table 2).
Site-specific analysis. Analyzing by site, a beneficial effect
of maternal supplementation was seen in India and Peru at 2
mo postpartum. The benefit was of a greater magnitude in
India both in the difference in breast milk retinol (10.3 nmol/g
fat, 95% CI 4.6, 16) and the difference in proportion of
mothers with breast milk retinol  28 nmol/g fat (22.2%,
95% CI 36.5, 7.9%) between vitamin A and placebo
groups (Table 2).
At 6 mo postpartum, the breast milk concentration tended
to be higher in the vitamin A-supplemented group in India (P
 0.05) (difference in means, 4 nmol/g fat, 95% CI 0.004,
8). There was no effect at 6 mo of supplementation on breast
milk retinol status in Ghana or Peru (Table 2). Maternal
supplementation did not affect breast milk retinol concentra-
tion or the proportion of women with low breast milk retinol
in any of the sites at 9 mo postpartum (Table 2).
Effect of maternal and EPI-linked supplementation
on vitamin A status of infants
Overall analysis. At 6 mo, serum retinol was not greater in
the vitamin A-supplemented group but there was a trend (P
 0.07) for a lower proportion of infants with serum retinol
 0.7 mol/L in this group (30.4 vs. 37%, 95% CI of differ-
ence, 13.7, 0.6%). The proportion of infants with a MRDR
 0.06 (44.2 vs. 52.9%, 95% CI of difference, 16.6, 0.9%)
was lower in the vitamin A-supplemented group, indicating
better vitamin A stores after supplementation. The reduction
in the proportion of infants with low stores was greater when
a higher MRDR cut-off value was used (Table 3).
At 9 mo, the beneficial effects on serum retinol and MRDR
status were no longer apparent except on the proportion of
infants with MRDR 0.09 (difference in proportions,6.2%,
95% CI 12.5, 0.02%).
Site-specific analysis. The overall benefit on infant vita-
min A status at 6 mo was due largely to effects in India and to
a lesser extent, Ghana. For instance, supplementation in-
creased serum retinol in India and decreased the proportion of
infants with low serum retinol in Ghana. The proportion of
infants with MRDR  0.06 was also lower due to vitamin A
only in Indian infants (62.9 vs. 76.5%, 95% CI of difference,
26.4, 0.9%) (Table 3).
At 9 mo, vitamin A stores were higher in the supplemented
infants only in India. The difference in proportions of infants
with MRDR  0.06 was 4.7% (95% CI 18.9, 9.4%), for
 0.09, 18.9% (95% CI 32.1, 5.7%) and for the  0.12
cut-off value, it was 12.6% (95% CI 24, 1.2%) in favor
of the supplemented group. An effect of supplementation on
serum retinol was not observed in 9-mo-old infants in any of
the study sites (Table 3).
TABLE 1
Baseline characteristics of enrolled subjects in vitamin A and control groups1
Characteristic
Overall Ghana India Peru
Vitamin A
n  1491
Placebo
n  1499
Vitamin A
n  539
Placebo
n  534
Vitamin A
n  460
Placebo
n  464
Vitamin A
n  492
Placebo
n  501
Infants
Age at enrollment, d 23.4  3.0 23.4  2.9 24.5  2.9 24.5  2.9 23.1  2.6 23.0  2.6 22.5  3.2 22.6  3.1
Males, n (%) 792 (53) 752 (50) 264 (49) 254 (48) 244 (53) 238 (51) 284 (58) 260 (52)
Breast-fed, n (%) 1489 (99.9) 1494 (99.7) 539 (100) 533 (99.8) 458 (99.6) 461 (99.4) 492 (100) 500 (99.8)
Infants weight at
enrollment, kg 3.6  0.6 3.6  0.6 3.7  0.5 3.6  0.6 3.2  0.6 3.2  0.5 3.9  0.5 3.9  0.5
Birth order, n 3.8  1.8 3.8  1.8 4.2  2.0 4.5  2.1 3.4  1.4 3.5  1.3 3.7  1.7 3.5  1.6
Mothers
Night blindness during
pregnancy, n (%) 62 (4) 65 (4) 5 (1) 4 (1) 8 (2) 11 (2) 49 (10) 50 (10)
Age of mother, y 25.4  5.6 25  5.4 26  6.3 26.2  6.6 24.2  4.1 24.2  4.0 26.2  6.4 25.5  6.1
Mothers’ years of
education, n 5  4.5 4.9  4.6 3  4 2.5  3.8 4.1  4.5 4.0  4.5 8.0  3.3 8.2  3.2
Breast milk retinol,
nmol/g fat 52.2  27.4 51.6  26.4 60.9  26.5 58.8  24.2 37.5  23.1 38.7  27.4 56.4  26.4 55.7  23.2
1 All values are means  SD or n (%).
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DISCUSSION
Maternal supplementation at the dose used in the current
study improved breast milk retinol at 2 mo postpartum but the
effect was not sustained to 6 or 9 mo. Previous studies from
Bangladesh with the same dose reported a significant effect on
breast milk retinol concentration up to 6 mo postpartum (13,15).
There is some evidence that a higher dose might give a more
extended benefit. Studies that used a  90-mg dose reported
improved breast milk retinol concentrations at 6–9 mo postpar-
tum (7,16,17). A recently proposed strategy is to give two doses
of 60 mg each to the mother instead of a single 60-mg dose as in
the present study during the 8-wk period after delivery (18).
Maternal and immunization-linked infant supplementa-
tion, at the doses used, improved vitamin A status indicators
at 6 mo in India and Ghana but the benefit at 9 mo was limited
to some improvement in vitamin A stores only in India.
Mortality reduction after vitamin A supplementation has been
clearly demonstrated in infants and children older than 6 mo,
but this benefit has not been shown consistently in younger
infants. A study from Indonesia reported a reduction in mor-
tality after supplementation to newborns (19), whereas two
others in which infants were supplemented with or without
maternal supplementation found no benefit (6,20). Increasing
the immunization-linked vitamin A dose from 7.5 to 15 mg
has also been proposed for improving vitamin A status be-
tween 6 and 9 mo of age. The efficacy of these higher doses in
improving vitamin A status or mortality and morbidity is not
yet known.
The maternal and infant supplementation strategy used
here was more effective in reducing the risk of very low
vitamin A stores, as indicated by higher MRDR cut-off
values. The conventionally used MRDR cut-off value of
0.06 for identifying children 1–5 y of age with low vita-
min A stores in developing countries is based on data from
TABLE
Overall and site-specific effect of maternal vitamin A supplementation given as 60 mg retinol palmitate
Indicator
Overall Ghana
Vitamin A Placebo Difference (95% CI) Vitamin A Placebo Difference (95% CI)
Infant age 2 mo n  322 n  309 n  123 n  124
Breast milk retinol, nmol/g fat 49.8  24.6 42.7  22.1 7.1 (3.4, 10.8)* 56.4  22.8 50.6  21.0 5.8 (2.8, 5.8)
Breast milk retinol 28 nmol/g fat 49 (15.2) 79 (25.6) 10.4 (16.6, 4.1)* 8 (6.5) 16 (12.9) 6.4 (13.7, 0.9)
Infant age 6 mo n  340 n  334 n  121 n  114
Breast milk retinol, nmol/g fat 42.9  21.6 41.8  25.8 1.1 (2.5, 4.7) 52.8  21.8 50.6  22.9 2.2 (3.5, 8)
Breast milk retinol 28 nmol/g fat 91 (26.8) 109 (32.6) 5.8 (12.8, 1) 14 (11.6) 15 (13.2) 1.6 (10.8, 6.8)
Infant age 9 mo n  276 n  294 n  94 n  78
Breast milk retinol, nmol/g fat 43.6  22.4 45.2  27.9 1.6 (5.8, 2.5) 49.7  19.4 54.5  25.4 4.8 (11.7, 2.1)
Breast milk retinol 28 nmol/g fat 76 (27.5) 86 (29.2) 1.7 (9.1, 5.7) 12 (12.8) 8 (10.3) 2.5 (7, 12)
1 All values are means  SD or n (%); * significant difference, P  0.05. CI, confidence interval.
TABLE
Overall and site-specific effect of maternal and infant vitamin A supplementation on vitamin A status of mothers given
Indicator
Overall Ghana
Vitamin A Placebo Difference (95% CI) Vitamin A Placebo Difference (95% CI)
Infant age 6 wk n  315 n  309 n  119 n  123
Serum retinol, mol/L 0.65  0.23 0.66  0.22 0.01 (0.05, 0.03) 0.66  0.23 0.69  0.23 0.03 (0.08, 0.03)
Serum retinol 0.70 mol/L 197 (62.5) 192 (62.1) 0.4 (7.2, 8.0) 66 (55.5) 74 (60.2) 4.7 (17.1, 7.7)
Infants with MRDR n  291 n  289 n  99 n  103
0.06 238 (81.8) 227 (78.5) 3.2 (3.2, 9.7) 75 (75.8) 78 (75.7) 0 (11.8, 11.8)
0.09 151 (51.9) 156 (54.0) 2.1 (10.2, 6.0) 46 (46.5) 51 (49.5) 3.0 (16.8, 10.7)
0.12 92 (31.6) 113 (39.1) 7.5 (15.2, 0.3) 26 (26.3) 36 (34.9) 8.7 (21.3, 4.0)
Infant age 6 mo n  332 n  330 n  118 n  113
Serum retinol, mol/L 0.83  0.29 0.80  0.27 0.03 (0.01, 0.08) 0.73  0.27 0.68  0.26 0.05 (0.03, 0.11)
Serum retinol 0.70 mol/L 101 (30.4) 122 (37.0) 6.5 (13.7, 0.6) 51 (43.2) 64 (56.6) 13.4 (26.2, 0.6)*
Infants with MRDR n  308 n  308 n  94 n  93
0.06 136 (44.2) 163 (52.9) 8.8 (16.6, 0.9)* 41 (43.6) 50 (53.8) 10.1 (24.4, 4.1)
0.09 51 (16.6) 84 (27.3) 10.7 (17.2, 4.2)* 18 (19.1) 26 (27.9) 8.8 (20.9, 3.3)
0.12 20 (6.5) 46 (14.9) 8.4 (13.3, 3.6)* 4 (4.2) 10 (10.8) 6.5 (14, 1.0)
Infant age 9 mo n  293 n  286 n  92 n  79
Serum retinol, mol/L 0.86  0.31 0.85  0.30 0.01 (0.04, 0.06) 0.72  0.28 0.74  0.34 0.02 (0.11, 0.08)
Serum retinol 0.70 mol/L 87 (29.7) 88 (30.8) 1.1 (8.6, 6.4) 44 (47.8) 39 (49.4) 1.5 (16.6, 13.5)
Infants with MRDR n  278 n  266 n  79 n  61
0.06 103 (37.1) 97 (36.5) 0.6 (7.5, 8.7) 36 (45.6) 24 (39.3) 6.2 (10.2, 22.7)
0.09 37 (13.3) 52 (19.5) 6.2 (12.5, 0.02)* 12 (15.2) 12 (19.7) 4.5 (17.2, 8.2)
0.12 19 (6.8) 30 (11.3) 4.4 (9.3, 0.4) 5 (6.3) 5 (8.2) 1.9 (10.6, 6.9)
1 All values are means  SD or n (%); * significant difference; P  0.05. CI, confidence interval.
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Indonesia (10 –12) and is higher than the 0.03 cut-off
value used for U.S. children (21). There are no well-
established norms for defining low vitamin A stores in
infants in developing countries. Data from the current study
and from a recent study in Bangladesh suggest that higher
MRDR cut-off values of 0.09 or 0.12 are more specific
indicators of low vitamin A stores in infants in developing
countries (13).
The prevalence of subclinical vitamin A deficiency (serum
retinol  0.7 mmol/L) varied among the study sites and the
effect of supplementation was related to the level of deficiency
in the infants. It is therefore appropriate that multicenter
studies of micronutrient supplementation be conducted either
in countries with similar levels of deficiency or that these be
designed to have adequate power to detect the effect at each
site. The latter option would result in a greater generalizability
of findings.
In conclusion, maternal and immunization-linked infant
supplementation in the doses used modestly increased the
vitamin A status of the infants at 6 mo of age. Additional
strategies must be considered to avoid health consequences of
vitamin A deficiency in the 6- to 9-mo period.
LITERATURE CITED
1. World Health Organization (1995) Global prevalence of vitamin A
deficiency. MDIS Working paper no. 2, WHO/NUT 95–3. WHO, Geneva, Switzer-
land.
2. Beaton, G. H., Martorell, R. & Aronson, K. J. (1993) Effectiveness of
vitamin A supplementation in the control of young child morbidity and mortality in
developing countries. State of the Art Series Nutritional Policy Discussion Paper
no. 13. United Nations Administrative Committee on Coordination/Subcommittee
on Nutrition. United Nations, New York, NY.
3. Fawzi, W. W., Chalmers, T. C., Herrera, M. G. & Mosteller, F. (1993)
Vitamin A supplementation and child mortality: a meta-analysis. J. Am. Med.
Assoc. 269: 898–903.
4. Glasziou, P. P. & Mackerras, D.E.M. (1993) Vitamin A supplementation
in infectious disease: a meta-analysis. Br. Med. J. 306: 366–370.
5. World Health Organization (1993) Using immunization contacts to
2
18–42 d postpartum on breast milk vitamin A status of lactating mothers in Ghana, India and Peru1
India Peru
Vitamin A Placebo Difference (95% CI) Vitamin A Placebo Difference (95% CI)
n  92 n  86 n  107 n  99
38.5  23.4 28.2  14.3 10.3 (4.6, 16.0)* 51.9  24.5 45.4  22 6.5 (0.02, 13.1)*
32 (34.8) 49 (57) 22.2 (36.5, 7.9)* 9 (8.4) 14 (14.1) 5.7 (14.4, 2.9)
n  106 n  107 n  113 n  113
28.9  15.2 24.9  14.4 4 (0.004, 8) 45.4  19.8 48.8  29.2 3.4 (10, 3.1)
63 (59.4) 71 (66.4) 7 (19.9, 6) 14 (12.4) 23 (20.4) 8 (17.6, 1.6)
n  94 n  104 n  88 n  112
31.6  18.4 32.3  26 0.7 (7, 5.5) 49.9  24.3 50.7  27.1 0.8 (8, 6.3)
50 (53.2) 61 (58.6) 5.5 (19.3, 8.4) 14 (15.9) 17 (15.2) 0.7 (9.4, 10.9)
3
60 mg retinol palmitate 18–42 d postpartum and infants given 7.5 mg at 6, 10 and 14 wk of age in Ghana, India and Peru1
India Peru
Vitamin A Placebo Difference (95% CI) Vitamin A Placebo Difference (95% CI)
n  98 n  95 n  98 n  91
0.57  0.24 0.55  0.23 0.03 (0.04, 0.09) 0.70  0.18 0.73  0.17 0.03 (0.08, 0.02)
75 (76.5) 77 (81.1) 4.5 (16.0, 7.0) 56 (57.1) 41 (45.1) 12.1 (2.1, 26.2)
n  95 n  95 n  97 n  91
83 (87.4) 86 (90.5) 3.2 (12.1, 5.7) 80 (82.5) 63 (69.2) 12.4 (0.2, 24.6)*
70 (73.7) 75 (78.9) 5.3 (17.3, 6.8) 35 (36.1) 30 (33.0) 3.1 (10.5, 16.7)
59 (62.1) 66 (69.5) 7.4 (20.8, 6.1) 7 (7.2) 11 (12.1) 4.9 (13.3, 3.6)
n  97 n  99 n  117 n  118
0.91  0.36 0.81  0.29 0.1 (0.001, 0.19)* 0.88  0.21 0.89  0.20 0.01 (0.06, 0.04)
25 (25.8) 35 (35.4) 9.6 (22.4, 3.2) 25 (21.4) 23 (19.5) 1.9 (8.4, 12.2)
n  97 n  98 n  117 n  117
61 (62.9) 75 (76.5) 13.6 (26.4, 0.9)* 34 (29.1) 38 (32.5) 3.4 (15.2, 8.4)
31 (31.9) 54 (55.1) 23.1 (36.7, 9.6)* 2 (1.7) 4 (3.4) 1.7 (5.8, 2.3)
16 (16.5) 35 (35.7) 19.2 (31.2, 7.2)* 0 1 (0.8) —
n  94 n  94 n  107 n  113
0.93  0.36 0.87  0.35 0.06 (0.04, 0.16) 0.91  0.24 0.91  0.20 0.0 (0.05, 0.06)
23 (24.5) 32 (34.0) 9.6 (22.5, 3.4) 20 (18.7) 17 (15.0) 3.6 (6.2, 13.6)
n  93 n  94 n  106 n  111
51 (54.8) 56 (59.6) 4.7 (18.9, 9.4) 16 (15.1) 17 (15.3) 0.2 (9.8, 9.3)
22 (23.6) 40 (42.6) 18.9 (32.1, 5.7)* 3 (2.8) 0 —
13 (14.0) 25 (26.6) 12.6 (24.0, 1.2)* 1 (0.9) 0 —
VITAMIN A SUPPLEMENTATION OF MOTHERS AND INFANTS 3247
 by on August 4, 2010 
jn.nutrition.org
D
ow
nloaded from
 
combat vitamin A deficiency. Report of an informal consultation, June 30-July 1,
1992. WHO/NUT/EPI/93.1. WHO, Geneva, Switzerland.
6. World Health Organization/Child Health and Development (1998) Im-
munization-Linked Vitamin A study Group. Randomized trial to assess benefits
and safety of vitamin A supplementation linked to immunization in early infancy.
Lancet 352: 1257–1263.
7. Stoltzfus, R. J., Hakimi, M., Miller, K. W., Rasmussen, K. M., Dawiesah, S.,
Habicht, J. P. & Dibley, M. J. (1993) High dose vitamin A supplementation of
breast-feeding Indonesian mothers: vitamin A status of mother and infant. J. Nutr.
123: 666–675.
8. Lucas, A., Gibbs, J.A.H., Lyster, R.L.J. & Baum, J. D. (1978) Creama-
tocrit: simple clinical technique for estimating fat concentration and energy value
of human milk. Br. Med. J. 1: 1018–1020.
9. World Health Organization (1996) Indicators for assessing vitamin A
deficiency and their application in monitoring and evaluating intervention pro-
grams. WHO/NUT/96: 10. WHO, Geneva, Switzerland.
10. Tanumihardjo, S. A., Muhilal, Yuniar, Y., Permaesih, D., Sulaiman, Z.,
Karyadi, D. & Olson, J. A. (1990) Vitamin A status in preschool-age Indonesia
children as assessed by the modified relative-dose-response assay. Am. J. Clin.
Nutr. 52: 1068–1072.
11. Tanumihardjo, S. A., Permaesih, D., Dahro, A. M., Rustan, E., Muhilal,
Karyadi, D. & Olson, J. A. (1994) Comparison of vitamin A status assessment
techniques in children from two Indonesian villages. Am. J. Clin. Nutr. 60: 136–
141.
12. Tanumihardjo, S. A., Cheng, J. C., Permaesih, D., Muherdiyantiningsih,
Rustan, E., Muhilal, Karyadi, D. & Olson, J. A. (1996) Refinement of the
modified-relative-dose-response test as a method for assessing vitamin A status
in a field setting: experience with Indonesian children. Am. J. Clin. Nutr. 64:
966–971.
13. Rice, A. L., Stoltzfus, R. J., de Francisco, A., Chakraborty, J., Kjolhede,
C. L. & Wahed, M. A. (1999) Maternal vitamin A or -carotene supplementation
in lactating Bangladeshi women benefits mothers and infants but does not
prevent subclinical deficiency. J. Nutr. 129: 356–365.
14. Smith, P. G. & Morrow, R. H., eds. (1991) Methods for Field Trials of
Interventions against Tropical Diseases: Toolbox, pp. 52–60. Oxford University
Press, Oxford, UK.
15. Roy, S. K., Islam, A., Molla, A., Akramuzzaman, S. M., Jahan, F. & Fuchs,
G. (1997) Impact of a single megadose of vitamin A at delivery on breastmilk
of mothers and their infants. Eur. J. Clin. Nutr. 51: 302–307.
16. Muhilal, Permaesih, D., Saidin, M., Murdiana, A., Wiramihardja, K. K. &
Karyadi, D. (1985) Dampak pemberian vitamin A dosis tinggi pada ibu men-
yusui terhadap status vitamin A anak. Penelit. Gizi Makanan 8: 5–19.
17. Thanangkul O., Promkutkaew, C., Waniyapong, T. & Damrongsak, D.
(1974) Comparison of the effects of a single high dose of vitamin A given to
mother and infant upon plasma levels of vitamin A in the infant. Presented at a
joint WHO/USAID meeting: The Control of Vitamin A Deficiency: Priorities for
Research and Action Programmes. NUT/WP/74.114, November 25–29, 1974,
Jakarta, Indonesia.
18. deBenoist, B., Martines, J. & Goodman, T. (2001) Vitamin A supple-
mentation and the control of vitamin A deficiency: conclusions. Food Nutr. Bull.
22: 335–337.
19. Humphrey, J. H., Agoestina, T., Wu, L., Usman, A., Nurachim, M., Su-
bardja, D., Hidayat, S., Tielsch, J., West, K. P., Jr. & Sommer, A. (1996) Impact
of neonatal vitamin A supplementation on infant morbidity and mortality. J. Pe-
diatr. 128: 489–496.
20. West, K. P., Jr., Katz, J., Shrestha, S. R., LeClerq, S. C., Khatry, S. K.,
Pradhan, E. K., Adhikari, R., Wu, L. S., Pokhrel, R. P. & Sommer, A. (1995)
Mortality of infants 6 mo of age supplemented with vitamin A: a randomized,
double-masked trial in Nepal. Am. J. Clin. Nutr. 62: 143–148.
21. Tanumihardjo, S. A., Koellner, P. G. & Olsen, J. A. (1990) The modified
relative dose response (MRDR) assay as an indicator of vitamin A status in a
population of well-nourished American children. Am. J. Clin. Nutr. 52: 1064–1067.
BAHL ET AL.3248
 by on August 4, 2010 
jn.nutrition.org
D
ow
nloaded from
 
